Todd Franklin Watanabe

Todd Franklin Watanabe

President and Chief Executive OfficeratArcutis Biotherapeutics· In proxies 2022–2025

Pay in FY2025+96% from the year before · Arcutis Biotherapeutics stock +108.5% the same year

Todd Franklin Watanabe was paid $7.2M in FY2025 (Dec), up 96%. Arcutis Biotherapeutics stock rose 108.5% that year.

Pay$100 in the stock at the end of FY21 → $140
Pay is from the Summary Compensation Table of each Arcutis Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arcutis BiotherapeuticsPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role +56%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?